{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:33:15Z","timestamp":1758123195044},"reference-count":7,"publisher":"Hogrefe Publishing Group","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p> Zusammenfassung. Angiomyolipome sind die h\u00e4ufigsten benignen Nierentumoren. Die meisten sind spontan aufgetretene Tumoren, mehrheitlich &lt;1,0 cm (ca. 54 %). Diese Tumoren wachsen nicht und sind harmlos. Auch Tumoren zwischen 1,0 und 2,5 cm (ca. 44 %) wachsen ganz selten und bleiben harmlos. Nur selten findet man gr\u00f6ssere Tumoren (ca. 2 %). Diese m\u00fcssen sorgf\u00e4ltig \u00fcberwacht werden, da Tumoren &gt;4,0 cm spontan gef\u00e4hrlich bluten k\u00f6nnen. Neben spontanem Auftreten gibt es auch Angiomyolipome in Rahmen des tuber\u00f6sen Sklerosekomplexes (TCS), hier sind die Tumoren \u00f6fters gr\u00f6sser, kombiniert mit Nierenzysten und Nierenzellkarzinomen. Die Messung der Echointensit\u00e4t ist f\u00fcr die Diagnose wichtig. <\/jats:p>","DOI":"10.1024\/1661-8157\/a003857","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T08:00:59Z","timestamp":1646208059000},"page":"123-129","source":"Crossref","is-referenced-by-count":1,"title":["CME-Sonografie 104: Angiomyolipome"],"prefix":"10.1024","volume":"111","author":[{"given":"Jan","family":"Tuma","sequence":"first","affiliation":[{"name":"Ultrasound Learning Center (ULC) der European Federation of Ultrasound in                Medicine and Biology (EFSUMB), Klinik Hirslanden, Z\u00fcrich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Dudeck","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Mikrotherapie, Klinik Hirslanden, Z\u00fcrich"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1245992"},{"key":"c2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35895-0"},{"key":"c3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1055\/s-0029-1203769","volume":"26","author":"Grawitz P","year":"1900","journal-title":"Dtsch Med Wochenschr"},{"key":"c4","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.05.011"},{"key":"c5","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0509-1"},{"key":"c6","unstructured":"Fittschen AP  . Pr\u00e4valenz und nat\u00fcrlicher Verlauf spontaner\n                  nicht-tuber\u00f6ser Sklerose-assoziierter Angiomyolipome der Niere. Universit\u00e4t\n                  Ulm; Dissertation:\n                  2013."},{"key":"c7","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.05.041"}],"container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T08:52:11Z","timestamp":1646815931000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1024\/1661-8157\/a003857"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003857","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}